These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15920331)

  • 1. What do patients want from their acute migraine therapy?
    Lantéri-Minet M
    Eur Neurol; 2005; 53 Suppl 1():3-9. PubMed ID: 15920331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
    Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
    Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
    Cutrer FM; Goadsby PJ; Ferrari MD; Lipton RB; Dodick DW; McCrory D; Williams P
    Clin Ther; 2004 Sep; 26(9):1533-45. PubMed ID: 15531016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do patients want from acute migraine treatment?
    Gallagher R
    Cephalalgia; 2004; 24 Suppl 2():8-15. PubMed ID: 15595989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical benefits of early triptan therapy for migraine.
    Láinez M
    Cephalalgia; 2004; 24 Suppl 2():24-30. PubMed ID: 15595991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and practice experience of almotriptan.
    Gendolla A
    Cephalalgia; 2004; 24 Suppl 2():16-23. PubMed ID: 15595990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Almotriptan in triptan-naïve patients: new evidence of benefits.
    Pascual J
    Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
    Diener HC
    Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying the benefits of the AwM study in the clinic.
    Dodick DW
    Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment.
    Tfelt-Hansen P
    Headache; 2008 Apr; 48(4):601-5. PubMed ID: 18377382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining response in migraine: which endpoints are important?
    Edmeads J
    Eur Neurol; 2005; 53 Suppl 1():22-8. PubMed ID: 15920334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of almotriptan in postmarketing surveillance studies.
    Pascual J
    Eur Neurol; 2005; 53 Suppl 1():34-40. PubMed ID: 15920336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Triptans--pivotal event in migraine treatment].
    Lusić I; Bilić I
    Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
    Sandrini G; Dahlöf CG; Mathew N; Nappi G
    Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
    Malik SN; Hopkins M; Young WB; Silberstein SD
    Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.
    Cevoli S; D'Amico D; Martelletti P; Valguarnera F; Del Bene E; De Simone R; Sarchielli P; Narbone M; Testa L; Genco S; Bussone G; Cortelli P
    Cephalalgia; 2009 Dec; 29(12):1285-93. PubMed ID: 19438916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction?
    D'Amico D; Moschiano F; Bussone G
    Expert Rev Neurother; 2006 Jul; 6(7):1087-97. PubMed ID: 16831121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis.
    Göbel H
    Expert Rev Neurother; 2010 Apr; 10(4):499-506. PubMed ID: 20367203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.